Anti-angiogenic therapy has immense clinical potential to not only impede tumor growth but also to inhibit tumor metastases. The first small molecule anti-angiogenic agent to enter clinical trials was the fumagillin derivative, TNP-470 (AGM1470), despite a limited knowledge of its mode of action. Our long-term goal is the exploration of TNP-470's molecular mechanism of action and the application of this information in the development of novel anti-angiogenic agents. We previously identified methionine aminopeptidase 2 (MetAP2) as the direct binding protein of fumagillin, and demonstrated that TNP-470 functions via p53 and p21 to induce its G, cell cycle arrest. To understand better the role of MetAP-2 in angiogenesis, we have generated a null-MetAP-2 and several MetAP-2-conditional knockout mouse lines. We have shown that induced loss of MetAP-2 in the endothelium results in an embryonic lethality at a similar developmental stage observed when other proteins known to be important in angiogenesis are required. Interestingly, complete loss of MetAP-2 results in an earlier embryonic lethality and defective gastrulation. We have subsequently shown that TNP-470 treatment or MetAP-2 knock down (via antisense morpholino oligonucleotides) in zebrafish result in a cell morphogenetic defect identical to misregulation of a non-canonical Wnt signaling pathway. This is consistent with the previously reported finding in Drosophila that MetAP-2 loss of function mutation results in ommatidial rotation defects and loss of ventral tissue in the eye, which is another phenotype indicative of defects in the non-canonical Wnt planar cell polarity (PCP) pathway. These genetic results strongly suggest that the non-canonical Wnt signaling pathway is regulated by TNP-470 via inhibition of MetAP2. In this study, we plan to characterize adult MetAP-2 KO mice histologically, behaviorally, and, in particular, for their angiogenic and tumor-bearing potential. We also plan to study the role that MetAP-2 plays in the non-canonical Wnt pathway and the importance of this pathway in endothelial cell growth control. Finally, we plan to identify and validate downstream MetAP-2 substrates. The combination of biochemical and cell culture approaches in the murine models provides a unique opportunity to characterize the relevant step or target for TNP-470 anti-angiogenesis intervention. The information generated from this study will contribute new information regarding angiogenic regulation and may provide new targets for the development of additional anti-angiogenic agents

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA083049-06A1
Application #
6875887
Study Section
Drug Discovery and Molecular Pharmacology Study Section (DMP)
Program Officer
Woodhouse, Elizabeth
Project Start
1999-07-09
Project End
2008-08-31
Budget Start
2004-09-30
Budget End
2005-08-31
Support Year
6
Fiscal Year
2004
Total Cost
$403,078
Indirect Cost
Name
Yale University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Raina, Kanak; Noblin, Devin J; Serebrenik, Yevgeniy V et al. (2014) Targeted protein destabilization reveals an estrogen-mediated ER stress response. Nat Chem Biol 10:957-62
Sundberg, Thomas B; Darricarrere, Nicole; Cirone, Pasquale et al. (2011) Disruption of Wnt planar cell polarity signaling by aberrant accumulation of the MetAP-2 substrate Rab37. Chem Biol 18:1300-11
Ju, Rong; Cirone, Pasquale; Lin, Shengda et al. (2010) Activation of the planar cell polarity formin DAAM1 leads to inhibition of endothelial cell proliferation, migration, and angiogenesis. Proc Natl Acad Sci U S A 107:6906-11
Hines, John; Ju, Rong; Dutschman, Ginger E et al. (2010) Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides. J Pharmacol Exp Ther 334:729-38
Cirone, Pasquale; Lin, Shengda; Griesbach, Hilary L et al. (2008) A role for planar cell polarity signaling in angiogenesis. Angiogenesis 11:347-60
Yeh, Jing-Ruey J; Ju, Rong; Brdlik, Cathleen M et al. (2006) Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Proc Natl Acad Sci U S A 103:10379-84
Zhang, Yi; Yeh, Jing Ruey; Mara, Andrew et al. (2006) A chemical and genetic approach to the mode of action of fumagillin. Chem Biol 13:1001-9
Brdlik, Cathleen M; Crews, Craig M (2004) A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases. J Biol Chem 279:9475-80
Yeh, Jing-Ruey J; Crews, Craig M (2003) Chemical genetics: adding to the developmental biology toolbox. Dev Cell 5:11-9
Koh, Brian; Crews, Craig M (2002) Chemical genetics: a small molecule approach to neurobiology. Neuron 36:563-6

Showing the most recent 10 out of 11 publications